Paul Geudens

Paul Geudens has extensive experience in the medical industry, with various roles and positions held over the years. Paul currently serves as the Chief Commercial Officer (CCO) at Tegus Medical GmbH since November 2022. Prior to this, they were a Strategic Advisor at Tegus Medical GmbH from July 2022 to December 2022.

Paul Geudens is also an Investor at Perfuze since March 2022 and at Protembis GmbH since September 2018. Paul previously worked as a Partner and Managing Director at Quarterback Consulting since February 2012.

In terms of board memberships, Paul Geudens was a Board Member at Perfuze from September 2019 to November 2021.

Some of their past roles include serving as the Chief Commercial Officer at Vivasure Medical from June 2017 to November 2021, Vice President Sales and Marketing at Neuravi from July 2013 to July 2017, Vice President Operations at CALIBER THERAPEUTICS from November 2012 to March 2014, International Vice President Sales and Marketing at Surpass Medical from February 2012 to December 2012, and Vice President Sales and Marketing at Stentys from August 2009 to February 2012.

Paul Geudens attended the London Business School, but no further details are provided regarding their degree, field of study, or dates of enrollment.